Alterations in this system may facilitate breast cancer progression and metastasis, whereas inhibiting JAK-STAT signaling in breast cancer could provide viable therapeutic approaches to address treatment resistance [28,29]. The gene discussed is SOAT1; the disease is breast cancer.